Zobrazeno 1 - 10
of 155
pro vyhledávání: '"Matthew R, Porembka"'
Autor:
John D. Karalis, Lynn Y. Yoon, Suntrea T. G. Hammer, Changjin Hong, Min Zhu, Ibrahim Nassour, Michelle R. Ju, Shu Xiao, Esther C. Castro-Dubon, Deepak Agrawal, Jorge Suarez, Scott I. Reznik, John C. Mansour, Patricio M. Polanco, Adam C. Yopp, Herbert J. Zeh, Tae Hyun Hwang, Hao Zhu, Matthew R. Porembka, Sam C. Wang
Publikováno v:
Journal of Translational Medicine, Vol 20, Iss 1, Pp 1-13 (2022)
Abstract Background Lenvatinib is a multitargeted tyrosine kinase inhibitor that is being tested in combination with immune checkpoint inhibitors to treat advanced gastric cancer; however, little data exists regarding the efficacy of lenvatinib monot
Externí odkaz:
https://doaj.org/article/eefb831987264d6b88bacc7638ab3ccd
Autor:
Jae-Ho Cheong, Sam C. Wang, Sunho Park, Matthew R. Porembka, Alana L. Christie, Hyunki Kim, Hyo Song Kim, Hong Zhu, Woo Jin Hyung, Sung Hoon Noh, Bo Hu, Changjin Hong, John D. Karalis, In-Ho Kim, Sung Hak Lee, Tae Hyun Hwang
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-9 (2022)
The ability to predict the survival and response to treatment of cancer patients may improve patient care. Here, the authors generate a 32 gene signature that can predict the survival and response to treatment in gastric cancer patients.
Externí odkaz:
https://doaj.org/article/471e0417c3904579a47020eb5e6fd8a8
Autor:
Sunho Park, John D. Karalis, Changjin Hong, Jean R. Clemenceau, Matthew R. Porembka, In-Ho Kim, Sung Hak Lee, Sam C. Wang, Jae-Ho Cheong, Tae Hyun Hwang
Publikováno v:
Clinical Cancer Research. 29:1077-1085
Purpose:We sought to identify biomarkers that predict overall survival (OS) and response to immune checkpoint inhibitors (ICI) for patients with gastric cancer.Experimental Design:This was a retrospective study of multiple independent cohorts of pati
Autor:
Aya Kamaya, Christopher Fung, Jean-Luc Szpakowski, David T. Fetzer, Andrew J. Walsh, Yewande Alimi, David B. Bingham, Michael T. Corwin, Nirvikar Dahiya, Helena Gabriel, Walter G. Park, Matthew R. Porembka, Shuchi K. Rodgers, Mitchell E. Tublin, Xin Yuan, Yang Zhang, William D. Middleton
Publikováno v:
Radiology. 305:277-289
Gallbladder polyps (also known as polypoid lesions of the gallbladder) are a common incidental finding. The vast majority of gallbladder polyps smaller than 10 mm are not true neoplastic polyps but are benign cholesterol polyps with no inherent risk
Publikováno v:
Surgical Oncology Clinics of North America. 31:707-719
Contrast-enhanced intraoperative ultrasound (CE-IOUS) is a relatively new but valuable tool that is increasingly used as an adjunct to computed tomography, MRI, and IOUS for patients undergoing liver surgery. CE-IOUS has an important role in 2 main s
Autor:
Michelle R. Ju, John D. Karalis, Matthieu Chansard, M. Mathew Augustine, Eric Mortensen, Sam C. Wang, Matthew R. Porembka, Herbert J. Zeh, Adam C. Yopp, Patricio M. Polanco
Publikováno v:
Annals of Surgical Oncology. 29:8413-8420
Autor:
Gilbert Z. Murimwa, John D. Karalis, Jennie Meier, Jingsheng Yan, Hong Zhu, Caitlin A. Hester, Matthew R. Porembka, Sam C. Wang, John C. Mansour, Herbert J. Zeh, Adam C. Yopp, Patricio M. Polanco
Publikováno v:
Annals of Surgical Oncology.
Autor:
Tae Hyun Hwang, Jae-Ho Cheong, Sam C. Wang, Sung Hak Lee, In-Ho Kim, Matthew R. Porembka, Jean R. Clemenceau, Changjin Hong, John D. Karalis, Sunho Park
Supplementary Figure 1. ACTA2 expression was elevated in the molecular subtype with the worst prognosis (Group 4). Supplementary Figure 2. ACTA2 expression stratified by microsatellite stability status in the pooled cohort. Supplementary Figure 3. Al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b515ea2c027052c3a3c819964993a7c
https://doi.org/10.1158/1078-0432.22489955
https://doi.org/10.1158/1078-0432.22489955
Autor:
Tae Hyun Hwang, Jae-Ho Cheong, Sam C. Wang, Sung Hak Lee, In-Ho Kim, Matthew R. Porembka, Jean R. Clemenceau, Changjin Hong, John D. Karalis, Sunho Park
Supplementary Table 1. Univariable associations of the multivariable Cox proportional hazards model in the Yonsei cohort.Supplementary Table 2. Clinical characteristics of patients in the pooled validation cohort.Supplementary Table 3. Univariable as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24193f4a3e7a3fc03ed428091ae14a2e
https://doi.org/10.1158/1078-0432.22489952
https://doi.org/10.1158/1078-0432.22489952
Autor:
Tae Hyun Hwang, Jae-Ho Cheong, Sam C. Wang, Sung Hak Lee, In-Ho Kim, Matthew R. Porembka, Jean R. Clemenceau, Changjin Hong, John D. Karalis, Sunho Park
Purpose:We sought to identify biomarkers that predict overall survival (OS) and response to immune checkpoint inhibitors (ICI) for patients with gastric cancer.Experimental Design:This was a retrospective study of multiple independent cohorts of pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83488eab830779602926f5237d7accec
https://doi.org/10.1158/1078-0432.c.6533069.v1
https://doi.org/10.1158/1078-0432.c.6533069.v1